Synergistic benefit of combined amlodipine plus atorvastatin on neuronal damage after stroke in Zucker metabolic rat

Brain Research

Volumn 1368, Issue , 2011, Pages 317-323

  Kawai, Hiromi ^a   Deguchi, Shoko ^a   Deguchi, Kentaro ^a   Yamashita, Toru ^a   Ohta, Yasuyuki ^a   Shang, Jingwei ^a   Tian, Fengfeng ^a   Zhang, Xuemei ^a   Liu, Ning ^a   Liu, Wentao ^a   Ikeda, Yoshio ^a   Matsuura, Tohru ^a   Abe, Koji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Amlodipine; Atorvastatin; Cerebral infarction; Inflammatory; Oxidative stress; Zucker rat

Indexed keywords

4 HYDROXYNONENAL; 8 HYDROXYDEOXYGUANOSINE; ADVANCED GLYCATION END PRODUCT; AMLODIPINE; ANTIOXIDANT; ATORVASTATIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALE; NERVE INJURY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; STROKE; ZUCKER DIABETIC FATTY RAT;

AMLODIPINE; ANIMALS; ANTICHOLESTEREMIC AGENTS; CALCIUM CHANNEL BLOCKERS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HEPTANOIC ACIDS; MALE; NEURONS; PYRROLES; RATS; RATS, ZUCKER; STROKE;

ANIMALIA; RATTUS;

EID: 78651107869     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.10.046     Document Type: Article

References (31)

1. K. Abe, M. Aoki, J. Kawagoe, T. Yoshida, A. Hattori, K. Kogure, and Y. Itoyama Ischemic delayed neuronal death. A mitochondrial hypothesis Stroke 26 1995 1478 1489
2. P. Amarenco, J. Bogousslavsky, A. Callahan III, L.B. Goldstein, M. Hennerici, A.E. Rudolph, H. Sillesen, L. Simunovic, M. Szarek, K.M. Welch, and J.A. Zivin High-dose atorvastatin after stroke or transient ischemic attack N Engl J. Med. 355 2006 549 559
3. H. Annoura, K. Nakanishi, M. Uesugi, A. Fukunaga, A. Miyajima, Y. Tamura-Horikawa, and S. Tamura A novel class of Na+ and Ca2+ channel dual blockers with highly potent anti-ischemic effects Bioorg. Med. Chem. Lett. 9 1999 2999 3002
4. J.F. Arenillas, P. Sandoval, N. Perez de la Ossa, M. Millan, C. Guerrero, D. Escudero, L. Dorado, E. Lopez-Cancio, J. Castillo, and A. Davalos The metabolic syndrome is associated with a higher resistance to intravenous thrombolysis for acute ischemic stroke in women than in men Stroke 40 2009 344 349
5. L. Cui, X. Zhang, R. Yang, L. Wang, L. Liu, M. Li, and W. Du Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: down-regulated 12/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability Brain Res. 1325 2010 164 173
6. M. Endres, U. Laufs, Z. Huang, T. Nakamura, P. Huang, M.A. Moskowitz, and J.K. Liao Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase Proc. Natl Acad. Sci. USA 95 1998 8880 8885
7. J.A. Farmer Aggressive lipid therapy in the statin era Prog. Cardiovasc. Dis. 41 1998 71 94
8. F. Franzoni, A. Quinones-Galvan, F. Regoli, E. Ferrannini, and F. Galetta A comparative study of the in vitro antioxidant activity of statins Int. J. Cardiol. 90 2003 317 321
9. B. Hajipour, M.H. Somi, F. Saberifar, M.R. Hemmati, N.A. Asl, A. Moein, A.M. Vatankhah, A.R. Nourazar, and M.R. Nasirizade Simvastatin attenuates intestinal ischemia/reperfusion induced injury in rat Folia Morphol. (Warsz) 68 2009 156 162
10. T. Hayashi, M. Sakurai, Y. Itoyama, and K. Abe Oxidative damage and breakage of DNA in rat brain after transient MCA occlusion Brain Res. 832 1999 159 163
11. T. Hayashi, K. Hamakawa, S. Nagotani, G. Jin, F. Li, K. Deguchi, Y. Sehara, H. Zhang, I. Nagano, M. Shoji, and K. Abe HMG CoA reductase inhibitors reduce ischemic brain injury of Wistar rats through decreasing oxidative stress on neurons Brain Res. 1037 2005 52 58
12. H. Kawai, T. Yamashita, Y. Ohta, K. Deguchi, S. Nagotani, X. Zhang, Y. Ikeda, T. Matsuura, and K. Abe Tridermal tumorigenesis of induced pluripotent stem cells transplanted in ischemic brain J. Cereb. Blood Flow Metab. 30 8 2010 1487 1493
13. S.H. Lee, Y.H. Kim, Y.J. Kim, and B.W. Yoon Atorvastatin enhances hypothermia-induced neuroprotection after stroke J. Neurol. Sci. 275 2008 64 68
14. K.E. Loke, E.J. Messina, S. Mital, and T.H. Hintze Impaired nitric oxide modulation of myocardial oxygen consumption in genetically cardiomyopathic hamsters J. Mol. Cell. Cardiol. 32 2000 2299 2306
15. V. Lukic-Panin, T. Kamiya, H. Zhang, T. Hayashi, A. Tsuchiya, Y. Sehara, K. Deguchi, T. Yamashita, and K. Abe Prevention of neuronal damage by calcium channel blockers with antioxidative effects after transient focal ischemia in rats Brain Res. 1176 2007 143 150
16. S. Malik, N.D. Wong, S.S. Franklin, T.V. Kamath, G.J. L'Italien, J.R. Pio, and G.R. Williams Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults Circulation 110 2004 1245 1250
17. S. Nagotani, T. Hayashi, K. Sato, W. Zhang, K. Deguchi, I. Nagano, M. Shoji, and K. Abe Reduction of cerebral infarction in stroke-prone spontaneously hypertensive rats by statins associated with amelioration of oxidative stress Stroke 36 2005 670 672
18. L.H. Opie, and R. Schall Evidence-based evaluation of calcium channel blockers for hypertension: equality of mortality and cardiovascular risk relative to conventional therapy J. Am. Coll. Cardiol. 39 2002 315 322
19. A. Rami, A. Langhagen, and S. Steiger Focal cerebral ischemia induces upregulation of Beclin 1 and autophagy-like cell death Neurobiol. Dis. 29 2008 132 141
20. M. Rodriguez-Yanez, J. Agulla, R. Rodriguez-Gonzalez, T. Sobrino, and J. Castillo Statins and stroke Ther. Adv. Cardiovasc. Dis. 2 2008 157 166
21. B. Schaller, and R. Graf Cerebral ischemia and reperfusion: the pathophysiologic concept as a basis for clinical therapy J. Cereb. Blood Flow Metab. 24 2004 351 371
22. S. Shiraya, T. Miyake, M. Aoki, F. Yoshikazu, S. Ohgi, M. Nishimura, T. Ogihara, and R. Morishita Inhibition of development of experimental aortic abdominal aneurysm in rat model by atorvastatin through inhibition of macrophage migration Atherosclerosis 202 2009 34 40
23. F.Y. Sun, X. Lin, L.Z. Mao, W.H. Ge, L.M. Zhang, Y.L. Huang, and J. Gu Neuroprotection by melatonin against ischemic neuronal injury associated with modulation of DNA damage and repair in the rat following a transient cerebral ischemia J. Pineal Res. 33 2002 48 56
24. A. Tsuchiya, S. Nagotani, T. Hayashi, K. Deguchi, Y. Sehara, T. Yamashita, H. Zhang, V. Lukic, T. Kamiya, and K. Abe Macrophage infiltration, lectin-like oxidized-LDL receptor-1, and monocyte chemoattractant protein-1 are reduced by chronic HMG-CoA reductase inhibition Curr. Neurovasc. Res. 4 2007 268 273
25. N.D. Vaziri, Z.G. Xu, A. Shahkarami, K.T. Huang, B. Rodriguez-Iturbe, and R. Natarajan Role of AT-1 receptor in regulation of vascular MCP-1, IL-6, PAI-1, MAP kinase, and matrix expressions in obesity Kidney Int. 68 2005 2787 2793
26. I. Villegas, A.R. Martin, W. Toma, and C.A. de la Lastra Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, protects against gastric ischemia-reperfusion damage in rats: role of oxygen free radicals generation Eur. J. Pharmacol. 505 2004 195 203
27. K. Yamagata, S. Ichinose, and M. Tagami Amlodipine and carvedilol prevent cytotoxicity in cortical neurons isolated from stroke-prone spontaneously hypertensive rats Hypertens. Res. 27 2004 271 282
28. Z.G. Zhang, W. Tsang, L. Zhang, C. Powers, and M. Chopp Up-regulation of neuropilin-1 in neovasculature after focal cerebral ischemia in the adult rat J. Cereb. Blood Flow Metab. 21 2001 541 549
29. Q. Zhou, and J.K. Liao Rho kinase: an important mediator of atherosclerosis and vascular disease Curr. Pharm. Des. 15 2009 3108 3115
30. L.M. Zucker Hereditary obesity in the rat associated with hyperlipemia Ann. NY Acad. Sci. 131 1965 447 458
31. L.M. Zucker, and H.N. Antoniades Insulin and obesity in the Zucker genetically obese rat "fatty" Endocrinology 90 1972 1320 1330